Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

34.36
+1.905.85%
Post-market: 34.560.2000+0.58%19:30 EDT
Volume:339.92K
Turnover:11.62M
Market Cap:2.38B
PE:-47.99
High:34.62
Open:32.97
Low:32.80
Close:32.46
52wk High:38.54
52wk Low:18.85
Shares:69.31M
Float Shares:12.94M
Volume Ratio:0.62
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7160
EPS(LYR):-2.5873
ROE:-33.57%
ROA:-13.53%
PB:7.61
PE(LYR):-13.28

Loading ...

Alamar Biosciences Q2 2026 Net Loss Widens to $13.2 Million; Revenue Rises 82% to $29.4 Million

Reuters
·
Aug 11

Earnings Flash (ALMR) Alamar Biosciences Posts Q2 Loss Per Share $0.22, vs. FactSet Est of $0.31 Loss

MT Newswires Live
·
Aug 11

Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate

Benzinga Earnings
·
Aug 11

Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures

THOMSON REUTERS
·
Aug 11

Alamar Biosciences Inc Expected to Post a Loss of 33 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 07

Earning Preview: Alamar Biosciences Q2 revenue is expected to decrease by 0.37%, and institutional views are bullish

Earnings Agent
·
Aug 03

Goldman Sachs-Backed Immunotherapy Pioneer Attovia (ATTO.US) Heads to Nasdaq: Targeting $212.5 Million in Top Funding, Adding Fuel to Biotech IPO Boom

Stock News
·
Jul 30

Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome

GlobeNewswire
·
Jul 29

Alzpath: Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease

THOMSON REUTERS
·
Jul 23

Alamar Biosciences Director Ian Ratcliffe Dies; Board Size Reduced to Five

Reuters
·
Jul 16

Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026

GlobeNewswire
·
Jul 15

BofA Securities Adjusts Alamar Biosciences Price Target to $30 From $27

MT Newswires Live
·
Jul 13

Alamar teams with research universities to launch proteomics initiatives

TIPRANKS
·
Jul 13

Alamar Biosciences Launches National Blood Biomarker Initiative for Alzheimer’s Research

Reuters
·
Jul 13

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling

GlobeNewswire
·
Jul 10

Alamar Biosciences Launches First Multiplexed Blood-based Immunoassay for Emtbr-tau, One of Most Important Biomarkers in Alzheimer's Disease Research

THOMSON REUTERS
·
Jul 07

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

GlobeNewswire
·
Jul 07

Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)

TIPRANKS
·
Jun 09

Alamar Biosciences initiated with an Outperform at Leerink

TIPRANKS
·
May 13